Abstract
(Abstracted from J Ultrasound Med 2022;41:157–162) Screening for fetal growth restriction (FGR) to identify those fetuses at increased risk of adverse neonatal outcomes has been difficult. Investigators have defined FGR in different ways, which has complicated efforts to validate results.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Paper version not known
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
